Contract 75F40124C00128
The General Hospital Corporation · Department Of Health And Human Services · September 25, 2024
The General Hospital Corporation was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 25, 2024 for $269,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Boston, MA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 4, 2026.
Contract details
- PIID
- 75F40124C00128
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Support- Professional: Other
- Place of performance
- Boston, MA
- First action
- September 25, 2024
- Latest action
- February 4, 2026
Description
TERMINATION SETTLEMENT FOR THE FULL TERMINATION FOR THE CONVENIENCE OF THE GOVERNMENT UNDER MOD P00001
Modification timeline
-
February 4, 2026Mod P00002 · Supplemental Agreement For Work Within Scope$268.7K
-
September 25, 2024Base awardENHANCE FDA SOURCE MODEL BY INCORPORATING AND ANALYZING STATE AND REGIONAL-LEVEL DATA BAA- FY24C3DP4$978.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40124C00128?
Contract 75F40124C00128 is a federal contract awarded to The General Hospital Corporation by Department Of Health And Human Services on September 25, 2024 for $269,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75F40124C00128?
The General Hospital Corporation won contract 75F40124C00128 from Department Of Health And Human Services.
How much is contract 75F40124C00128 worth?
Contract 75F40124C00128 has obligated $269,000 to date.